Sandostatin subcutaneous injection 50μg, from Novartis Pharma, contains octreotide acetate, a somatostatin analogue used to treat acromegaly and symptoms associated with metastatic carcinoid tumors and VIPomas. This injectable drug, YJ code 2499403A1037, is supplied as 50 μg per 1mL tube.
Sandostatin subcutaneous injection 50μg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →